SLC60A1 and vitiligo: Interfering with Mfsd4a in melanocytes co-cultured with vitiligo model T cells significantly improved melanocyte activity, inhibited the levels of inflammatory cytokines TNF-α, IL-1β, and IL-6, reduced melanocyte apoptosis, and inhibited JAK/STAT3 pathway activation.